Diversity

#Ascendis Pharma #BioIndustry Association #Cancer therapy #CHMP #Clinical trial #Diversity #European Medicines Agency #FDA #Gene therapy #Oncology #Paediatrics #Rare disease #uniQure #University of Queensland #Women in STEM

DDW Highlights: 10 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, figures showed the number of women in biotech leadership has stalled. Elsewhere, could… Read More

#Podcasts

Female CEO
#BioIndustry Association #Diversity #Women in STEM

Representation of women in biotech leadership stalls

Despite a marginal positive shift at CEO level, overall representation of women in leadership positions has stalled across the UK biotech sector, new figures have revealed.  The BioIndustry Association’s (BIA) report, ‘Women in Biotech Leadership: one year on’, combines PitchBook data with sector insights to track changes… Read More

#Business & Investment #Editor's Choice #News

#Artificial intelligence (AI) #Cancer research #Data management #Diversity #Oncology #Quantum computing

Opportunities and challenges in oncology

DDW Editor Reece Armstrong takes a look at some of the recent activity in cancer research and examines where the biggest opportunities are in oncology.  In January this year, researchers from the University of Toronto (UoT) and Insilico Medicine published a paper detailing how quantum computing combined with generative… Read More

#Cancer Research #Exclusive Content #Trends & Analysis

Diversity
#Clinical trials #Diversity #Drug development #Drug discovery #FDA #Inclusivity

Opinion: Are FDA plans enough to boost inclusivity within clinical trials?

DDW Editor Reece Armstrong examines whether recent FDA plans to boost diversity within clinical trials are enough to tackle the scale of the problem. In June this year, the US Food and Drug Administration (FDA) issued draft guidance designed to help boost the engagement of underrepresented communities within clinical… Read More

#Exclusive Content

Diversity
#Clinical trial design #Clinical trials #Diversity #University of Oxford

Deterrents to trial participation among ethnic minorities revealed

Safety and health concerns, time investment, and lack of support are the top three barriers to participation in clinical studies among ethnic minorities, according to a new report. The study examined the motivators and deterrents of clinical trial participation among ethnic minorities and outlined strategies sponsors can utilise… Read More

#News

ESG
#Charles River #Diversity #Environmental impact #ESG #Sustainability

Charles River achieves 92% renewable energy use

Charles River Laboratories has reported achieving 92% renewable energy usage worldwide in its 2023 Corporate Citizenship Report. The 2023 report evaluates the company’s progress across its strategic Environmental, Social and Governance (ESG) areas of focus: Accelerate Life-Saving Therapies; Lead with Integrity; Inspire our People; and Protect… Read More

#News

Woman reading on a tablet
#2023 #Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Biotech hubs #Cell and gene therapy #CRISPR #Diversity #Oncology #Regulatory

DDW top reads in 2023

DDW’s Senior Digital Content Editor Diana Spencer reviews the year’s top ten articles. DDW’s top 10 most popular articles for 2023 reflect the key subjects in drug discovery and development. In a record year for gene therapy approvals, it isn’t surprising that cell & gene therapy… Read More

#Exclusive Content

#Assay #Biologics / Biotechnology #Biopharma #Diversity #DNA #Drug development #Drug discovery #Gene sequencing #Ingredients / APIs / Fine chemicals #Synthetic biology #Women in Discovery #Women in STEM

New podcast: Overcoming different barriers in drug discovery

This is the latest episode of the free DDW narrated podcast, “Overcoming different barriers in drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Addressing the challenge of salt forms in drug discovery”, “… Read More

#News

Diversity equity inclusion
#Collaboration #Diversity

Diversity, Equity, and Inclusion Data Service for clinical development 

Phesi, a global provider of patient-centric data software and services, has partnered with Krystelis, a provider of medical writing and clinical trial transparency services, to launch its new Diversity, Equity, and Inclusion (DEI) Data Service.   A 2022 Phesi data analysis discovered 42% of US cancer trial cohorts… Read More

#News

Diversity
#Clinical trials #Diversity #Patient

Clinical Trials For All to educate public about clinical research

Educational campaign, Clinical Trials For All, has been launched to drive greater understanding, participation and diversity in clinical trials. Only 59% of Americans know about clinical research, 91% of Americans have never been invited to participate, and Black/African and Hispanic/Latino Americans are less than 12% of… Read More

#News

Diversity
#Clinical research #Clinical trials #Diversity #Drug development #Organoids

The importance of introducing diversity earlier in drug development 

DDW’s Reece Armstrong speaks to Shantanu Dhamija, VP of Strategy and Innovation at Molecular Devices about challenges of diversity in clinical trials and why induced pluripotent stem cells might be key to representing wider patient groups.   RA: Why is US clinical trial diversity at its… Read More

#Exclusive Content

ESG cloud icon green earth concept for environment
#Clinical trials #Diversity #ESG #Healthcare #ICON

Exclusive insight from ICON Cares 2022 ESG Report 

ICON, a healthcare intelligence and clinical research organisation, recently released its ICON Cares 2022 Environmental, Social and Governance (ESG) Report. Diarmaid Cunningham, Chief Administrative Officer at ICON, shares insight with DDW.  At ICON, we engage with our key stakeholders through a variety of methods and the environmental,… Read More

#Business & Investment #Exclusive Content #Regulatory

Diversity
#Clinical trial design #Clinical trials #Diversity #Inato #Inclusivity #Investment #Oncology

$20 million in new funding to make clinical trials more inclusive

Clinical trial technology platform Inato, based in Paris, France, has closed a $20 million Series A funding from investors including Cathay Innovation, Obvious Ventures, La Maison and Top Harvest Capital. With the new funding, Inato will advance its diversity product offering to meet the new FDA… Read More

#Business & Investment #News #Start-up Zone

#Diversity #Gender equality #International Women's Day #Life sciences #Pharmaceutical industry

Balancing the lack of gender equality at top leadership level 

Women in Life Science Denmark (WiLD), an inspiring and science-centric not-for-profit network for women in senior positions across industry and academia, launched in January 2023 to strengthen value creation in the Danish Life Sciences industry, while promoting talent, diversity and inclusiveness. DDW’s Megan Thomas caught up with WiLD to… Read More

#Business & Investment #Exclusive Content

International Women's Day
#Diversity #Gender equality #International Women's Day #Life sciences #Pharmaceutical industry

International Women’s Day: Female life science leaders

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. In its ‘Women in Business 2022’ report, Grant Thornton… Read More

#Exclusive Content